Pfizer has appeal for patient investors
Tariffs will add to share price pressure, but dividends keep rising and drug pipeline promising.
Tag: Pfizer
Weight loss drug war heats up
Pfizer and Roche have released promising early stage results, but Novo Nordisk and Eli Lilly have a big head start.
Drugmakers see booming demand for weight-loss drugs
Strong demand for Wegovy, Ozempic just scratching surface, says CEO of Novo Nordisk
Weight loss drugs Ozempic, Wegovy may be right for investors
Celebrity endorsements helping build market potential, analysts say
Covid fatigue takes toll on vaccine makers
Demand for boosters falls as virus seen as something less to be feared than managed
Recession resistant healthcare stocks offer stability and safety
Considered dull during the tech boom, these mature, global businesses are back in favour.
For vaccine makers, a year of consolidation
It should be another good year, but share prices may have limited upside.
Will Big Pharma’s Covid vaccine bet pay off?
Drug companies have won praise for a quick rollout of COVID vaccines. Are investors also winners?
Adam Mayers 